Condition: Cardiotoxicity · Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
To test whether the implementation of new diagnostic techniques (ultrasonography, speckle tracking, vascular stiffness study, cardiac MRI, and histologic studies) allows in CAYA (Childern, Adolescents, and Young Adults) cancer survivors a more sensitive and earlier identification of cardiovascular damage resulting from antineoplastic therapy that develops either acutely or remotely after completion of antineoplastic therapy.
This description comes directly from the study's public registry record.
Andrea Donti, MD · 051/309900 · andrea.donti@aosp.bo.it
Always discuss trial participation with your own doctor first.
| IRCCS - AOU di Bologna -Policlinico di Sant'Orsola UOC Pediatria | Bologna, Bologna, Italy | Recruiting |
| IRCCS AOU di Bologna -Policlinico di Sant'Orsola UO Cardiochirurgia pediatrica e dell'età evolutiva | Bologna, Bologna, Italy | Recruiting |
| IRCCS AOU di Bologna -Policlinico di Sant'Orsola UO Oncoematologia Pediatrica | Bologna, Bologna, Italy | Recruiting |
| IRCCS AOU di Bologna Policlinico di Sant'Orsola UO Cardiologia Pediatria e dell'età evolutiva | Bologna, Bologna, Italy | Recruiting |
| IRCCS AOU di Bologna Policlinico di Sant'Orsola UO Radiologia, sezione Cardio-Toraco-Vascolare | Bologna, Bologna, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07382141